Demethylation of ras-like estrogen-regulated growth inhibitor (RERG) has suppressed the ERK/NF-κB pathway and retarded the NPC progression by inhibiting the migration, invasion, and angiogenesis [144]. This evidence concerns the gene RERG and nasopharyngeal carcinoma.